BioSpace News Archive

Individuals with prediabetes and those with untreated type 2 diabetes had six times higher odds to achieve ≥10% weight loss compared to placebo

Canadians are proud of Canada’s health care system, which provides care based on need and not the ability to pay.

Haemonetics Corporation announced that the Company intends to publish fourth quarter and full fiscal year 2019 financial results at 6:00 am ET on Tuesday, May 7, 2019.

2SHB 1155 would have many unintended consequences that jeopardize patient care

Cesca Therapeutics Inc. announced financial and operating results for the fiscal year ended December 31, 2018 and provided a corporate update.

Veracyte, Inc. (Nasdaq: VCYT) announced that new data from the Afirma® Xpression Atlas suggest that the majority of newly diagnosed medullary thyroid cancers (MTC) are associated with variants from three genes.

April 25-26 event features sessions on caring for LGBTQ community and disaster response

Aquestive Therapeutics, Inc. announced that management will present at the H.C. Wainwright Global Life Sciences Conference to be held in London, UK on April 7 - 9.

On the heels of establishing a European based presence last year, Lachman Consultant Services, Inc., a leading provider of expert compliance, regulatory affairs, and technical services to life sciences organizations worldwide, will return to the ISPE Europe 2019 Annual Conference. Lachman is sponsoring the event on April 1-4, where they will be located in booth #60 at the Clayton Hotel Burlington Road, Dublin, Ireland.

Results establish favorable safety profile and show the potential for efficacy with once-weekly dosing of a next generation GLP-2 analog